RGLXF yields 6.90% · PFE yields 6.13%● Live data
📍 RGLXF pulled ahead of the other in Year 1
Combined, RGLXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGLXF + PFE for your $10,000?
RTL Group S.A., an entertainment company, operates television (TV) channels and radio stations, and provides streaming services in Germany, France, the Netherlands, Belgium, the United Kingdom, the United States, and internationally. The RTL Deutschland segment operates RTL, Vox, Super RTL, Toggo Plus, NTV, Nitro, Vox Up, and RTL Up free-to-air channels; RTL Crime, RTL Passion, RTL Living, GEO Television, and Now! thematic pay channels; and RTL Zwei, an equity participation in the free-to-air channel. This segment also offers streaming service RTL+; engages in content activities, such as the production companies RTL Studios and RTL News; and provision of RTL Radio Deutschland and ad-tech business, Smartclip. The Groupe M6 segment operates television channels; radio stations; and digital services, including mobile applications and IPTV services. The Fremantle segment is involved in the content production comprising of distribution and licensing business. The RTL Nederland segment operates RTL 4, RTL 5, RTL 7, RTL 8, RTL Z, RTL Lounge, RTL Crime, and RTL Telekids TV channels; and Videoland, a pay streaming service, as well as offers RTL XL, a catch-up TV service in the Netherlands. The Other segment operates RTL play, a streaming service; RTL-TVI; RTL Klub; Club RTL; RTL Most, a streaming platform; RTL Televizija; RTL 2; RTL Kockica children's channels; RTL Luxembourg; RTL Radio Letzebuerg; and RTL Tele Letzebuerg, a general interest TV channel. The company was founded in 1924 and is based in Luxembourg City, Luxembourg. RTL Group S.A. is a subsidiary of Bertelsmann Capital Holding GmbH.
Full RGLXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.